Error: Could not add to watchlist. X

PROLOR Biotech Ltd

+ Watchlist
PBTH:US
Acquired
PBTH:US was acquired by OPK:US
USD
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.39
Market Cap (USD)
-
Shares Outstanding (m)
63.855
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
PROLOR Biotech Inc. is a biopharmaceutical company. The Company develops therapeutic proteins. PROLOR offers treatment by using naturally occurring amino acid sequence to slow the removal of therapeutic proteins from the body without increasing toxicity or altering the overall biological activity.
ADDRESS
3 Sapir Street
Weizmann Science Park
Nes Ziona, 74140
Israel
PHONE
1-866-644-7811
  • Abraham Havron "Avri"
    Chief Executive Officer
  • Shai Novik
    President
  • Steve Schaeffer
    Chief Financial Officer
Show More